KOD Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
0
0
0
0
0
Cost of Revenue
0
0
0
0
0
Gross Profit
0
0
0
0
0
Operating Expenses
66.8M
+11.8%
59.8M
+4.0%
57.5M
-7.9%
62.4M
+12.3%
55.5M
R&D
56.1M
+15.5%
48.5M
+6.7%
45.5M
-9.9%
50.5M
+18.0%
42.8M
SG&A
10.8M
-4.2%
11.2M
-6.1%
12.0M
+0.7%
11.9M
-6.9%
12.8M
Operating Income
-66838000
-11.8%
-59777000
-4.0%
-57453000
+7.9%
-62352000
-12.3%
-55510000
EBITDA
-62726000
-12.7%
-55668000
-5.2%
-52909000
+8.4%
-57765000
-13.5%
-50916000
Net Income
-65643000
-12.9%
-58158000
-2.5%
-56736000
+7.7%
-61457000
-13.2%
-54313000
EPS (Basic)
$-1.05
-11.7%
$-0.94
+9.6%
$-1.04
+10.3%
$-1.16
-12.6%
$-1.03
EPS (Diluted)
$-1.05
-11.7%
$-0.94
+9.6%
$-1.04
+10.3%
$-1.16
-12.6%
$-1.03
Shares (Diluted)
62.6M
+1.2%
61.9M
+13.6%
54.4M
+3.0%
52.9M
+0.2%
52.8M
Kodiak Sciences (KOD) โ€” Financials